GoodRx Holdings Inc. (NASDAQ:GDRX) has seen 3.09 million shares traded in the last trading session. The company, currently valued at $15.72B, closed the last trade at $41.71 per share which meant it gained $1.98 on the day or 4.98% during that session. The GDRX stock price is -53.97% off its 52-week high price of $64.22 and 36.08% above the 52-week low of $26.66. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.99 million shares traded. The 3-month trading volume is 1.70 million shares.
The consensus among analysts is that GoodRx Holdings Inc. (GDRX) is an Overweight stock at the moment, with a recommendation rating of 2.40. 1 analysts rate the stock as a Sell, while 2 rate it as Overweight. 5 out of 15 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is $0.08.
GoodRx Holdings Inc. (NASDAQ:GDRX) trade information
Sporting 4.98% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the GDRX stock price touched $41.71 or saw a rise of 1.44%. Year-to-date, GoodRx Holdings Inc. shares have moved 3.40%, while the 5-day performance has seen it change 12.03%. Over the past 30 days, the shares of GoodRx Holdings Inc. (NASDAQ:GDRX) have changed 31.41%. Short interest in the company has seen 17.79 million shares shorted with days to cover at 7.18.
Wall Street analysts have a consensus price target for the stock at $42.57, which means that the shares’ value could jump 2.02% from current levels. The projected low price target is $28.00 while the price target rests at a high of $56.00. In that case, then, we find that the current price level is -34.26% off the targeted high while a plunge would see the stock lose 32.87% from current levels.
GoodRx Holdings Inc. (GDRX) estimates and forecasts
Figures show that GoodRx Holdings Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained 4.25% over the past 6 months, with this year growth rate of 0.00%, compared to 18.10% for the industry. Revenue growth from the last financial year stood is estimated to be 35.90%.
11 analysts offering their estimates for the company have set an average revenue estimate of $176.63 million for the current quarter. 11 have an estimated revenue figure of $194.68 million for the next quarter concluding in Sep 2021.
Earnings growth for 2021 is a modest -720.20% while over the next 5 years, the company’s earnings are expected to increase by 32.57%.
GoodRx Holdings Inc. is expected to release its next earnings report on May 13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
GoodRx Holdings Inc. (NASDAQ:GDRX)’s Major holders
Insiders own 9.19% of the company shares, while shares held by institutions stand at 69.89% with a share float percentage of 76.96%. Investors are also buoyed by the number of investors in a company, with GoodRx Holdings Inc. having a total of 241 institutions that hold shares in the company. The top two institutional holders are Wellington Management Group, LLP with over 4.54 million shares worth more than $177.25 million. As of Mar 30, 2021, Wellington Management Group, LLP held 6.53% of shares outstanding.
The other major institutional holder is Morgan Stanley, with the holding of over 3.56 million shares as of Mar 30, 2021. The firm’s total holdings are worth over $138.93 million and represent 5.12% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Morgan Stanley Inst Fund Tr-Discovery Port and Vanguard Total Stock Market Index Fund. As of Mar 30, 2021, the former fund manager holds about 1.89% shares in the company for having 1.31 million shares of worth $51.16 million while later fund manager owns 1.1 million shares of worth $42.82 million as of Mar 30, 2021, which makes it owner of about 1.58% of company’s outstanding stock.